BP000030-GD4: Recombinant Human FGF Basic
Source: E. coli-derived.
The FGF basic (bFGF/FGF-2/FGF2) activity is measured in a cell proliferation assay using NIH-3T3 mouse fibroblasts. The ED50 for this effect is less than 0.5 ng/ml.
Endotoxin Level: <1.0 EU per 1 ug of the protein by the LAL method.
Purity: > 95% by SDS-PAGE under reducing conditions.PA000307-Mab-C40046G: BFGF Monoclonal Antibody
Mouse Monoclonal Antibody;
Applications: ELISA;
Reactivity: Human;
Clone No: F-538.PA000573-Mab-C40047A: EPO Monoclonal Antibody
Mouse Monoclonal Antibody;
Applications: ELISA;
Clone No: 85;
Reactivity: Human.PA008014.m2cLA: In Vivo Grade Recombinant Anti-mouse PD-1 / VEGF-A Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone RMP1-14.1 / B20-4.1.1.1)
The in vivo grade recombinant anti-mouse PD-1 / VEGF-A bispecific antibody (mouse IgG2c LALAPG Kappa) was produced in mammalian cells.
Applications: immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.PA008015.m2cLA: In Vivo Grade Recombinant Anti-mouse PD-1 / VEGF-A Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone 29F.1A12.1 / B20-4.1.1.1)
The in vivo grade recombinant anti-mouse PD-1 / VEGF-A bispecific antibody (mouse IgG2c LALAPG Kappa) was produced in mammalian cells.
Applications: immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.PA008013.m2cLA: In Vivo Grade Recombinant Anti-mouse CD370 / CD47 Bispecific Antibody, Mouse IgG2c LALAPG Kappa (Clone 10B4 / A4)
The in vivo grade recombinant anti-mouse CD370 / CD47 bispecific antibody (mouse IgG2c LALAPG Kappa) was produced in mammalian cells.
Applications: immunohistochemistry (IHC), Flow Cytometry (FC), and various in vitro and in vivo functional assays.
Endotoxin Level: Less than 1 EU/mg of protein as determined by LAL method.BP000131-C041: Recombinant Mouse Interleukin-1 alpha (IL-1α) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of mouse D10S cells was found to be less than 0.01 ug/ml, corresponding to a Specific Activity of 1.0 x 108 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000131-C070: Recombinant Human Interleukin-1 alpha (IL-1α) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000140-C021: Recombinant Human Interleukin-17A (IL-17A) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent induction of IL-6 in primary human foreskin fibroblasts was found to be approximately 2 ug/ml, corresponding to a Specific Activity of 5 x 105 IU/mg.
Purity: > 95% by RP-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000162-C092: Recombinant Human Interleukin-17E (IL17E) Protein
Source: E. coli-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).